Market Cap 51.33M
Revenue (ttm) 60,000.00
Net Income (ttm) -11.14M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -18,566.67%
Debt to Equity Ratio 0.00
Volume 14,500
Avg Vol 17,394
Day's Range N/A - N/A
Shares Out 9.97M
Stochastic %K 31%
Beta 0.71
Analysts Strong Sell
Price Target $13.00

Company Profile

Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment of advanced Parkinson's disease that is in preclinical stage development; and POZ-lipids, a non-immunogenic alternative to the PEG-lipids in the lipid nanoparticles. The company also develops SER 214 a POZ conjugate of rotigotine for the treatment of early Parkinson's and Restless Leg Syndrome, which...

Industry: Biotechnology
Sector: Healthcare
Phone: 256 327 9630
Address:
601 Genome Way, Suite 2001, Huntsville, United States
BigSqueezeComing
BigSqueezeComing Jul. 15 at 10:59 AM
$SER pm gapper
0 · Reply
YasirTrades
YasirTrades Jul. 15 at 8:13 AM
Super squeeze in the making?!? Ticker AQMS AQMS is quietly holding the keys to battery sustainability. EVs are booming, but recycling is the missing piece and has the solution in hand. Government grants, patent protection, and low-float potential make this a dark horse winner. This isn’t just a clean-tech story it’s a future supply chain necessity. $BLMZ $COOT $SER $BMNR
0 · Reply
PSM_EmpowerTrading
PSM_EmpowerTrading Jul. 15 at 4:34 AM
🌅🌅 watchlist ✅️ $GRO mid 2.50 support, if above 3, have potential to 3.40/.50, signing 200 M deal with Fictor Energia ✅️ $XAGE low 4 support, if above 4.50, have potential to 4.80/5, announces merger news with True Health ✅️ $BLMZ low .20 support, if above .25, have potential to. 35/.40 ✅️ $SER low 6 support, if above 7, have potential to 7.50/80 ✅️ $IBG low 1 support, if above 1.50, have potential to 1.75/.80 ✅️ VBIX low 6 support, if above 6.50, have potential to 6.80/.90 ✅️ OPEN low 1 support, if above 1.20, have potential to 1.40/1.50 🚨🚨 The above tickers are not ideal for swing accumulation at current price 🎯 🎯 Ideal long stop loss if current support 🚫🚫 Avoid chasing long into strength near resistance 🎯🎯 Goal is GR🤑🤑N not GR🥵🥵D
1 · Reply
tariq7863a
tariq7863a Jul. 14 at 11:17 PM
$SER 6.50 or less tomorrow. don't be bag holders
0 · Reply
tariq7863a
tariq7863a Jul. 14 at 10:56 PM
$SER tomorrow 6.00 don't be bag holders
0 · Reply
stockanalysis_
stockanalysis_ Jul. 14 at 9:39 PM
After Hours Gainers: $GRO $SER $XAGE $MOVE $BHAT View the entire list here: https://stockanalysis.com/markets/afterhours/gainers/?ref=saveontrading
0 · Reply
littleimagination
littleimagination Jul. 14 at 4:09 PM
$SER Still long SER. Weird type of pricing, it always stays sideways in this $5 to $6. dollar range. Due to the low float and insider buying. When they want to move this stock, it will skip dollars at a time. SER will be fun to ride north of $100!
0 · Reply
JarvisFlow
JarvisFlow Jul. 14 at 11:00 AM
HC Wainwright & Co. has updated their rating for Serina Therapeutics ( $SER ) to Buy with a price target of 15.
0 · Reply
littleimagination
littleimagination Jun. 18 at 3:31 PM
$SER Still long SER and Wff, a newer low float Chinese ipo.
0 · Reply
jheerdink
jheerdink Jun. 10 at 6:34 PM
$SER $PFE https://finance.yahoo.com/news/registration-now-open-tribe-public-200500498.html
0 · Reply
Latest News on SER
Serina Therapeutics to Present at JonesResearch Virtual CNS Day

Apr 29, 2025, 6:00 AM EDT - 2 months ago

Serina Therapeutics to Present at JonesResearch Virtual CNS Day


Serina Therapeutics Announces Sale of UniverXome Subsidiary

Jan 15, 2025, 4:05 PM EST - 6 months ago

Serina Therapeutics Announces Sale of UniverXome Subsidiary


AgeX Therapeutics Reports Second Quarter 2023 Financial Results

Aug 14, 2023, 4:05 PM EDT - 2 years ago

AgeX Therapeutics Reports Second Quarter 2023 Financial Results


AgeX Therapeutics Reports First Quarter 2023 Financial Results

May 12, 2023, 4:05 PM EDT - 2 years ago

AgeX Therapeutics Reports First Quarter 2023 Financial Results


AgeX Therapeutics Receives Stock Exchange Deficiency Letter

Apr 26, 2023, 4:05 PM EDT - 2 years ago

AgeX Therapeutics Receives Stock Exchange Deficiency Letter


AgeX Therapeutics Reports Third Quarter 2022 Financial Results

Nov 10, 2022, 4:05 PM EST - 2 years ago

AgeX Therapeutics Reports Third Quarter 2022 Financial Results


AgeX Therapeutics Reports Second Quarter 2022 Financial Results

Aug 12, 2022, 4:05 PM EDT - 3 years ago

AgeX Therapeutics Reports Second Quarter 2022 Financial Results


BigSqueezeComing
BigSqueezeComing Jul. 15 at 10:59 AM
$SER pm gapper
0 · Reply
YasirTrades
YasirTrades Jul. 15 at 8:13 AM
Super squeeze in the making?!? Ticker AQMS AQMS is quietly holding the keys to battery sustainability. EVs are booming, but recycling is the missing piece and has the solution in hand. Government grants, patent protection, and low-float potential make this a dark horse winner. This isn’t just a clean-tech story it’s a future supply chain necessity. $BLMZ $COOT $SER $BMNR
0 · Reply
PSM_EmpowerTrading
PSM_EmpowerTrading Jul. 15 at 4:34 AM
🌅🌅 watchlist ✅️ $GRO mid 2.50 support, if above 3, have potential to 3.40/.50, signing 200 M deal with Fictor Energia ✅️ $XAGE low 4 support, if above 4.50, have potential to 4.80/5, announces merger news with True Health ✅️ $BLMZ low .20 support, if above .25, have potential to. 35/.40 ✅️ $SER low 6 support, if above 7, have potential to 7.50/80 ✅️ $IBG low 1 support, if above 1.50, have potential to 1.75/.80 ✅️ VBIX low 6 support, if above 6.50, have potential to 6.80/.90 ✅️ OPEN low 1 support, if above 1.20, have potential to 1.40/1.50 🚨🚨 The above tickers are not ideal for swing accumulation at current price 🎯 🎯 Ideal long stop loss if current support 🚫🚫 Avoid chasing long into strength near resistance 🎯🎯 Goal is GR🤑🤑N not GR🥵🥵D
1 · Reply
tariq7863a
tariq7863a Jul. 14 at 11:17 PM
$SER 6.50 or less tomorrow. don't be bag holders
0 · Reply
tariq7863a
tariq7863a Jul. 14 at 10:56 PM
$SER tomorrow 6.00 don't be bag holders
0 · Reply
stockanalysis_
stockanalysis_ Jul. 14 at 9:39 PM
After Hours Gainers: $GRO $SER $XAGE $MOVE $BHAT View the entire list here: https://stockanalysis.com/markets/afterhours/gainers/?ref=saveontrading
0 · Reply
littleimagination
littleimagination Jul. 14 at 4:09 PM
$SER Still long SER. Weird type of pricing, it always stays sideways in this $5 to $6. dollar range. Due to the low float and insider buying. When they want to move this stock, it will skip dollars at a time. SER will be fun to ride north of $100!
0 · Reply
JarvisFlow
JarvisFlow Jul. 14 at 11:00 AM
HC Wainwright & Co. has updated their rating for Serina Therapeutics ( $SER ) to Buy with a price target of 15.
0 · Reply
littleimagination
littleimagination Jun. 18 at 3:31 PM
$SER Still long SER and Wff, a newer low float Chinese ipo.
0 · Reply
jheerdink
jheerdink Jun. 10 at 6:34 PM
$SER $PFE https://finance.yahoo.com/news/registration-now-open-tribe-public-200500498.html
0 · Reply
jheerdink
jheerdink Jun. 9 at 8:20 PM
$SER Registration Is Now Open For Tribe Public’s CEO Presentation and Q&A Webinar Event "Is the Beaten Down Biotech Sector the Smartest Bet in Today's Volatile Market?" Featuring Serina Therapeutics’ CEO - Wednesday, June 11, 2025 -Entering year 5 of a biotech bear market, approximately 25% of the 700 – 800 publicly traded US biotech companies have negative enterprise values -Recognize the patterns that can lead to strong investment returns Meet with Serina’s CEO Steven A. Ledger Register at Smartest-Bet.TribePublic.com https://investors.serinatherapeutics.com/news/news-details/2025/Registration-Is-Now-Open-For-Tribe-Publics-CEO-Presentation-and-QA-Webinar-Event-Is-the-Beaten-Down-Biotech-Sector-the-Smartest-Bet-in-Todays-Volatile-Market/default.aspx
0 · Reply
jheerdink
jheerdink Jun. 4 at 6:22 PM
$SER Serina Therapeutics Strategically Adds Karuna Therapeutics’ CMO Dr. Stephen Brannan: A Power Move for CNS Innovation & Beyond ( $TAK $LLY ) https://vistapglobal.com/serina-therapeutics-strategically-adds-karuna-therapeutics-cmo-dr-stephen-brannan-a-power-move-for-cns-innovation-beyond-ser-bmy-tak-nvs-lly/ #
0 · Reply
littleimagination
littleimagination May. 16 at 12:44 PM
$SER Hold on tight to SER. Don't let them steal your shares for under $150.
0 · Reply
littleimagination
littleimagination May. 16 at 12:41 PM
$SER $ 3. dollar gap up. This is the type of stock that could follow RGC to 500!
0 · Reply
jheerdink
jheerdink May. 14 at 3:46 AM
$SER "We are energized by the substantial progress and strengthened foundation we've achieved in recent months. Our partnership with Enable Injections, combined with our proprietary POZ optimization technology, continues to advance SER-252 toward a differentiated product profile and potential best-in-class therapy for advanced Parkinson’s care. With new capital infusions in the first quarter and April from strategic investors, we remain focused on reaching key milestones, including dosing the first patient in our Phase 1b clinical trial by the fourth quarter of this year," said Steve Ledger, CEO of Serina Therapeutics. "Importantly, we are dedicated to expanding the impact of our POZ Platform and remain committed to pushing the boundaries of our platform’s potential, from neurological disorders to RNA-based and ADC therapeutics, to improve patient outcomes and quality of life." $PFE https://finance.yahoo.com/news/serina-therapeutics-reports-first-quarter-202300846.html
0 · Reply
Stangman88
Stangman88 May. 9 at 11:56 PM
0 · Reply
jheerdink
jheerdink Apr. 25 at 5:18 PM
$SER Serina Therapeutics - Enable Injections Presents Survey Results Highlighting Missed Opportunities in Subcutaneous Oncology Drug Development at AACR 2025 https://investors.serinatherapeutics.com/news/news-details/2025/Enable-Injections-Presents-Survey-Results-Highlighting-Missed-Opportunities-in-Subcutaneous-Oncology-Drug-Development-at-AACR-2025/default.aspx
0 · Reply
kshonstocks
kshonstocks Apr. 24 at 2:48 PM
$SER 200 dma b/o from scans
0 · Reply
Rage_Against_The_Machine
Rage_Against_The_Machine Apr. 14 at 8:29 PM
$SER secures $5M via private placement, issuing 962k shares of Series A Preferred at $5.18 (current share price). Funds target Phase 1 trial for SER-252 in Parkinson's. Dilution meets desperation - cash runway extended, but 8% cumulative dividends add pressure. Conversion terms suggest investors want common stock upside without the wait. https://www.sec.gov/Archives/edgar/data/1708599/000170859925000042/ser-20250408.htm
0 · Reply
jheerdink
jheerdink Apr. 9 at 2:41 AM
$SER Serina Therapeutics Secures $5 Million in Funding to Support Advancement of SER-252 into Clinical Development in Advanced Parkinson's Disease https://finance.yahoo.com/news/serina-therapeutics-secures-5-million-203000685.html
0 · Reply
DonCorleone77
DonCorleone77 Apr. 2 at 8:26 PM
$SER Serina Therapeutics files $100M mixed securities shelf
0 · Reply
littleimagination
littleimagination Apr. 2 at 2:27 PM
$SER Is SER the next Nmax? SER has lots of insider buying the past 12 months for some reason. Under 9 million shares. Very tiny float.
0 · Reply